Veraxa Biotech Holding AG (VRXAW) Assets (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Assets of $101.1 million for Q4 2025, up 4.5% year-over-year from $96.8 million in Q4 2024, and up 4.5% quarter-over-quarter from $96.8 million in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Assets (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Assets for 2 consecutive years, with $101.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets rose 4.5% year-over-year to $101.1 million; the TTM figure through Dec 2025 stood at $101.1 million (up 4.5% YoY), while the FY2025 annual figure was $101.1 million, up 4.5% from the prior year.
- Assets rose to $101.1 million in Q4 2025 per VRXAW's latest filing, from $96.8 million in the prior quarter.
- Across five years, Assets topped out at $101.1 million in Q4 2025 and bottomed at $96.8 million in Q4 2024.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.12 Mn |
| Dec 31, 2024 | 96.76 Mn |